Skip to main content

Advertisement

SpringerLink
Log in

Olfactory Function in SCA10

  • Original Paper
  • Published:
The Cerebellum Aims and scope Submit manuscript

Abstract

Although the main clinical manifestations of spinocerebellar ataxias (SCAs) result from damage of the cerebellum, other systems may also be involved. Olfactory deficits have been reported in other types of ataxias, especially in SCA3; however, there are no studies on olfactory deficits in SCA type 10 (SCA10). To analyze olfactory function of SCA10 patients compared with that of SCA3, Parkinson’s, and healthy controls. Olfactory identification was tested in three groups of 30 patients (SCA10, SCA3, and Parkinson’s disease (PD)) and 44 healthy controls using the Sniffin’ Sticks (SS16) test. Mean SS16 score was 11.9 ± 2.9 for the SCA10 group, 12.3 ± 1.9 for the SCA3 group, 6.6 ± 2.8 for the PD group, and 12.1 ± 2.0 for the control group. Mean SS16 score for the SCA10 group was not significantly different from the scores for the SCA3 and control groups but was significantly higher than the score for the PD group (p < 0.001) when adjusted for age, gender, and history of smoking. There was no association between SS16 scores and disease duration in the SCA10 or SCA3 groups or number of repeat expansions. SS16 and Mini Mental State Examination scores were correlated in the three groups: SCA10 group (r = 0.59, p = 0.001), SCA3 group (r = 0.50, p = 0.005), and control group (r = 0.40, p = 0.007). We found no significant olfactory deficits in SCA10 in this large series.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Teive HAG, Ashizawa T. Primary and secondary ataxias. Curr Opin Neurol. 2015;28(4):413–22.

    Article  Google Scholar 

  2. Matsuura T, Ashizawa T. Spinocerebellar ataxia type 10: a disease caused by a large ATTCT repeat expansion. Adv Exp Med Biol. 2002a;516:79–97.

    Article  CAS  Google Scholar 

  3. Matsuura T, Ashizawa T. Polymerase chain reaction amplification of expanded ATTCT repeat in spinocerebellar ataxia type 10. Ann Neurol. 2002b;51(2):271–2.

    Article  Google Scholar 

  4. Teive HAG, Roa BB, Raskin S, Fang P, Arruda WO, Neto YC, et al. Clinical phenotype of Brazilian families with spinocerebellar ataxia 10. Neurology. 2004;63(8):1509–12.

    Article  CAS  Google Scholar 

  5. Moscovich M, Munhoz RP, Teive HA, Raskin S, Carvalho M de J, Barbosa ER, et al. Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry. 2012;83(10):970–4.

    Article  Google Scholar 

  6. Moro A, Munhoz RP, Moscovich M, Arruda WO, Raskin S, Silveira-Moriyama L, et al. Nonmotor symptoms in patients with spinocerebellar ataxia type 10. Cerebellum. 2017;16(5–6):938–44.

    Article  Google Scholar 

  7. Teive HA, Munhoz RP, Raskin S, Arruda WO, de Paola L, Werneck LC, et al. Spinocerebellar ataxia type 10: frequency of epilepsy in a large sample of Brazilian patients. Mov Disord. 2010;25(16):2875–8.

    Article  Google Scholar 

  8. Moro A, Munhoz RP, Arruda WO, Raskin S, Moscovich M, Teive HA. Spinocerebellar ataxia type 3: subphenotypes in a cohort of Brazilian patients. Arq Neuropsiquiatr. 2014;72(9):659–62.

    Article  Google Scholar 

  9. Paulson H. Machado-Joseph disease/spinocerebellar ataxia type 3. Handb Clin Neurol. 2012;103:437–49.

    Article  Google Scholar 

  10. Ahlskog JE, Waring SC, Petersen RC, Esteban-Santillan C, Craig UK, O'Brien PC, et al. Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia. Neurology. 1998;51(6):1672–7.

    Article  CAS  Google Scholar 

  11. Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases. Arch Neurol. 1998;55(1):84–90.

    Article  CAS  Google Scholar 

  12. Silveira-Moriyama L, Guedes LC, Kingsbury A, Ayling H, Shaw K, Barbosa ER, et al. Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology. 2008;71(13):1021–6.

    Article  CAS  Google Scholar 

  13. Braga-Neto P, Felicio AC, Pedroso JL, Dutra LA, Bertolucci PH, Gabbai AA, et al. Clinical correlates of olfactory dysfunction in spinocerebellar ataxia type 3. Parkinsonism Relat Disord. 2011;17(5):353–6.

    Article  CAS  Google Scholar 

  14. Velazquez-Perez L, Fernandez-Ruiz J, Diaz R, Gonzalez RP, Ochoa NC, Cruz GS, et al. Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. J Neurol. 2006;253(9):1165–9.

    Article  Google Scholar 

  15. Fernandez-Ruiz J, Diaz R, Hall-Haro C, Vergara P, Fiorentini A, Nunez L, et al. Olfactory dysfunction in hereditary ataxia and basal ganglia disorders. Neuroreport. 2003;14(10):1339–41.

    Article  Google Scholar 

  16. Galvez V, Diaz R, Hernandez-Castillo CR, Campos-Romo A, Fernandez-Ruiz J. Olfactory performance in spinocerebellar ataxia type 7 patients. Parkinsonism Relat Disord. 2014;20(5):499–502.

    Article  Google Scholar 

  17. Connelly T, Farmer JM, Lynch DR, Doty RL. Olfactory dysfunction in degenerative ataxias. J Neurol Neurosurg Psychiatry. 2003;74(10):1435–7.

    Article  CAS  Google Scholar 

  18. Houlden H. Sniffing out the cerebellum. J Neurol Neurosurg Psychiatry. 2012;83(10):952–3.

    Article  Google Scholar 

  19. Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH. Suggestions for utilization of the mini-mental state examination in Brazil. Arq Neuropsiquiatr. 2003;61(3B):777–81.

    Article  Google Scholar 

  20. Teive HA, Munhoz RP, Arruda WO, Raskin S, Werneck LC, Ashizawa T. Spinocerebellar ataxia type 10—a review. Parkinsonism Relat Disord. 2011;17(9):655–61.

    Article  Google Scholar 

  21. Teive HA, Munhoz RP, Raskin S, Werneck LC. Spinocerebellar ataxia type 6 in Brazil. Arq Neuropsiquiatr. 2008;66(3B):691–4.

    Article  Google Scholar 

  22. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181–4.

    Article  CAS  Google Scholar 

  23. Kobal G, Hummel T, Sekinger B, Barz S, Roscher S, Wolf S. “Sniffin’ sticks”: screening of olfactory performance. Rhinology. 1996;34(4):222–6.

    CAS  PubMed  Google Scholar 

  24. Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717–20.

    Article  CAS  Google Scholar 

  25. Subramony SH. SARA—a new clinical scale for the assessment and rating of ataxia. Nat Clin Pract Neurol. 2007;3(3):136–7.

    Article  Google Scholar 

  26. Abele M, Riet A, Hummel T, Klockgether T, Wullner U. Olfactory dysfunction in cerebellar ataxia and multiple system atrophy. J Neurol. 2003;250(12):1453–5.

    Article  Google Scholar 

  27. Hawkes C. Olfaction in neurodegenerative disorder. J Mov Disord. 2003;18(4):364–72.

    Article  Google Scholar 

  28. Silveira-Moriyama L, Azevedo AM, Ranvaud R, Barbosa ER, Doty RL, Lees AJ. Applying a new version of the Brazilian-Portuguese UPSIT smell test in Brazil. Arq Neuropsiquiatr. 2010a;68(5):700–5.

    Article  Google Scholar 

  29. Morley JF, Weintraub D, Mamikonyan E, Moberg PJ, Siderowf AD, Duda JE. Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson’s disease. Movement disorders. J Mov Disord. 2011;26(11):2051–7.

  30. Silveira-Moriyama L, Hughes G, Church A, Ayling H, Williams DR, Petrie A, et al. Hyposmia in progressive supranuclear palsy. J Mov Disord 2010b;25(5):570–7.

    Article  Google Scholar 

  31. Kovacs T. Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders. Ageing Res Rev. 2004;3(2):215–32.

    Article  Google Scholar 

  32. Hummel T, Kobal G. Differences in human evoked potentials related to olfactory or trigeminal chemosensory activation. Electroencephalogr Clin Neurophysiol. 1992;84(1):84–9.

    Article  CAS  Google Scholar 

  33. Savic I. Brain imaging studies of the functional organization of human olfaction. Neuroscientist. 2002;8(3):204–11.

    Article  Google Scholar 

  34. Yousem DM, Williams SC, Howard RO, Andrew C, Simmons A, Allin M, et al. Functional MR imaging during odor stimulation: preliminary data. Radiology. 1997;204(3):833–8.

    Article  CAS  Google Scholar 

  35. Savic I, Gulyas B, Berglund H. Odorant differentiated pattern of cerebral activation: comparison of acetone and vanillin. Hum Brain Mapp. 2002;17(1):17–27.

    Article  Google Scholar 

  36. Qureshy A, Kawashima R, Imran MB, Sugiura M, Goto R, Okada K, et al. Functional mapping of human brain in olfactory processing: a PET study. J Neurophysiol. 2000;84(3):1656–66.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Movement Disorders Unit, Neurology Service, Internal Medicine Department, Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brazil

    Mariana Moscovich, Adriana Moro & Helio A. G. Teive

  2. Department of Neurology, UKSH, Campus Kiel, Christian-Albrechts-University, Kiel, Germany

    Mariana Moscovich & Karen McFarland

  3. Movement Disorders Centre, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

    Renato Puppi Munhoz

  4. Group for Advanced Molecular Investigation (NIMA), School of Health and Biosciences, Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Paraná, Brazil

    Salmo Raskin

  5. Department of Neurology, Houston Methodist, Weill Cornell Medical College, Houston, TX, USA

    Tetsuo Ashizawa

  6. Postgraduate Program in Medicine, Universidade Nove de Julho, Uninove, São Paulo, Brazil

    Laura Silveira-Moriyama

  7. Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, 1 Wakefield Street, London, WC1N 1PJ, UK

    Laura Silveira-Moriyama

  8. Departamento de Neurologia, Universidade Estadual de Campinas, UNICAMP, Campinas, Brazil

    Laura Silveira-Moriyama

  9. Departamento de Neurologia, Universidade de São Paulo, USP, São Paulo, Brazil

    Laura Silveira-Moriyama

Authors
  1. Mariana Moscovich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Renato Puppi Munhoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adriana Moro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Salmo Raskin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Karen McFarland
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tetsuo Ashizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Helio A. G. Teive
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Laura Silveira-Moriyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

M Moscovich conceptualized the study, analyzed the data in the study, drafted the manuscript, and revised the manuscript. R P Munhoz drafted the manuscript and revised the manuscript. H A Teive designed the study and revised the manuscript. S Raskin revised the manuscript. A Moro revised the manuscript. K McFarland revised the manuscript. T Ashizawa revised the manuscript. L Silveira-Moriyama designed the study, interpreted the data in the study, analyzed the data in the study, drafted the manuscript, and revised the manuscript.

Corresponding author

Correspondence to Mariana Moscovich.

Ethics declarations

Informed consent was obtained from all participants, and the protocol was approved by the local (UFPR) ethics committee.

Conflict of Interest

Dr. Moscovich, Dr. Munhoz, Dr. Moro, Dr. Raskin, and Dr. McFarland report no disclosure. Dr. Ashizawa is funded by NIH grant NS083564. Teive received personal compensation for educational activities with Allergan, Ipsen, Teva, and UCB and serves as an editor-in-chief of Arquivos de Neuro-Psiquiatria and editorial board member of Movement Disorder Clinical Practice, the Journal of Neurology Research, Parkinson’s Disease, Current Neurology and Neuroscience Reports, and Arquivos de Neuropsiquiatria. Dr. Laura Silveira-Moriyama received travel grants from Teva and supervised scholarships from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moscovich, M., Munhoz, R.P., Moro, A. et al. Olfactory Function in SCA10. Cerebellum 18, 85–90 (2019). https://doi.org/10.1007/s12311-018-0954-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12311-018-0954-1

Keywords

Search

Navigation